<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Khalil M</submitter><funding>NCI NIH HHS</funding><pagination>5283-5292</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11236845</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>31(8)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>New persistent opioid use (NPOU) after surgery has been identified as a common complication. This study sought to assess the long-term health outcomes among patients who experienced NPOU after gastrointestinal (GI) cancer surgery.&lt;h4>Methods&lt;/h4>Patients who underwent surgery for hepato-pancreato-biliary and colorectal cancer between 2007 and 2019 were identified using the Surveillance, Epidemiology, and End Results (SEER)-Medicare-linked database. Mixed-effect multivariable logistic regression and Cox proportional hazard models were used to estimate the risk of mortality and hospital visits related to falls, respiratory events, or pain symptoms.&lt;h4>Results&lt;/h4>Among 15,456 patients who underwent GI cancer surgery, 967(6.6%) experienced NPOU. Notably, the patients at ris</pubmed_abstract><journal>Annals of surgical oncology</journal><pubmed_title>Long-term Health Outcomes of New Persistent Opioid Use After Gastrointestinal Cancer Surgery.</pubmed_title><pmcid>PMC11236845</pmcid><funding_grant_id>HHSN261201800032I</funding_grant_id><funding_grant_id>HHSN261201800009C</funding_grant_id><funding_grant_id>HHSN261201800009I</funding_grant_id><funding_grant_id>HHSN261201800015C</funding_grant_id><funding_grant_id>HHSN261201800032C</funding_grant_id><funding_grant_id>HHSN261201800015I</funding_grant_id><pubmed_authors>Khalil M</pubmed_authors><pubmed_authors>Woldesenbet S</pubmed_authors><pubmed_authors>Khan MMM</pubmed_authors><pubmed_authors>Tsai S</pubmed_authors><pubmed_authors>Munir MM</pubmed_authors><pubmed_authors>Endo Y</pubmed_authors><pubmed_authors>Rashid Z</pubmed_authors><pubmed_authors>Dillhoff M</pubmed_authors><pubmed_authors>Altaf A</pubmed_authors><pubmed_authors>Katayama E</pubmed_authors><pubmed_authors>Pawlik TM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Long-term Health Outcomes of New Persistent Opioid Use After Gastrointestinal Cancer Surgery.</name><description>&lt;h4>Background&lt;/h4>New persistent opioid use (NPOU) after surgery has been identified as a common complication. This study sought to assess the long-term health outcomes among patients who experienced NPOU after gastrointestinal (GI) cancer surgery.&lt;h4>Methods&lt;/h4>Patients who underwent surgery for hepato-pancreato-biliary and colorectal cancer between 2007 and 2019 were identified using the Surveillance, Epidemiology, and End Results (SEER)-Medicare-linked database. Mixed-effect multivariable logistic regression and Cox proportional hazard models were used to estimate the risk of mortality and hospital visits related to falls, respiratory events, or pain symptoms.&lt;h4>Results&lt;/h4>Among 15,456 patients who underwent GI cancer surgery, 967(6.6%) experienced NPOU. Notably, the patients at ris</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Aug</publication><modification>2025-04-19T01:04:27.866Z</modification><creation>2025-04-07T12:02:35.154Z</creation></dates><accession>S-EPMC11236845</accession><cross_references><pubmed>38762641</pubmed><doi>10.1245/s10434-024-15435-1</doi></cross_references></HashMap>